1. Home
  2. SRRK vs EPR Comparison

SRRK vs EPR Comparison

Compare SRRK & EPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$40.03

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Logo EPR Properties

EPR

EPR Properties

HOLD

Current Price

$55.85

Market Cap

4.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
EPR
Founded
2012
1997
Country
United States
United States
Employees
289
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.4B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SRRK
EPR
Price
$40.03
$55.85
Analyst Decision
Strong Buy
Buy
Analyst Count
11
10
Target Price
$55.10
$59.19
AVG Volume (30 Days)
1.1M
775.9K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
N/A
6.34%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.60
Revenue Next Year
$449.79
$4.05
P/E Ratio
N/A
$25.00
Revenue Growth
N/A
N/A
52 Week Low
$22.71
$41.75
52 Week High
$49.82
$62.08

Technical Indicators

Market Signals
Indicator
SRRK
EPR
Relative Strength Index (RSI) 32.95 42.92
Support Level $29.32 $55.86
Resistance Level $42.54 $58.33
Average True Range (ATR) 2.24 1.37
MACD -0.62 -0.56
Stochastic Oscillator 1.77 4.35

Price Performance

Historical Comparison
SRRK
EPR

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

Share on Social Networks: